Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1977 1
1980 3
1982 1
1984 2
1985 1
1986 4
1987 1
1988 2
1989 1
1991 1
1992 2
1993 2
1994 5
1995 4
1996 5
1997 5
1998 6
1999 4
2000 7
2001 6
2002 4
2003 7
2004 10
2005 8
2006 4
2007 5
2008 18
2009 18
2010 10
2011 11
2012 7
2013 14
2014 6
2015 5
2016 10
2017 10
2018 10
2019 8
2020 11
2021 6
2022 7
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Results by year

Filters applied: . Clear all
Page 1
Indicators of cure for women living after uterine and ovarian cancers: a population-based study.
Giudici F, De Paoli A, Toffolutti F, Guzzinati S, Francisci S, Bucchi L, Gatta G, Demuru E, Mallone S, Cin AD, Caldarella A, Cuccaro F, Migliore E, Gambino ML, Ravaioli A, Puppo A, Ferrante M, Carrozzi G, Stracci F, Musolino A, Gasparotti C, Cavallo R, Mazzucco W, Vitale MF, Cascone G, Ballotari P, Ferretti S, Mangone L, Rizzello RV, Sampietro G, Mian M, Boschetti L, Galasso R, Bella F, Piras D, Sessa A, Seghini P, Fanetti AC, Pinna P, De Angelis R, Serraino D, Maso LD, Working Group A. Giudici F, et al. Among authors: ravaioli a. Am J Epidemiol. 2024 Apr 15:kwae044. doi: 10.1093/aje/kwae044. Online ahead of print. Am J Epidemiol. 2024. PMID: 38629583
Cure indicators and prevalence by stage at diagnosis for breast and colorectal cancer patients: A population-based study in Italy.
Dal Maso L, Toffolutti F, De Paoli A, Giudici F, Francisci S, Bucchi L, Zorzi M, Fusco M, Caldarella A, Rossi S, De Angelis R, Botta L, Ravaioli A, Casella C, Musolino A, Vitale MF, Mangone L, Fanetti AC, Carpin E, Burgio Lo Monaco MG, Migliore E, Gambino ML, Ferrante M, Stracci F, Gasparotti C, Carrozzi G, Cavallo R, Mazzucco W, Ballotari P, Ferretti S, Sampietro G, Rizzello RV, Boschetti L, Cascone G, Mian M, Pesce MT, Piras D, Galasso R, Bella F, Seghini P, Pinna P, Crocetti E, Serraino D, Guzzinati S; AIRTUM Working Group. Dal Maso L, et al. Among authors: ravaioli a. Int J Cancer. 2024 Mar 23. doi: 10.1002/ijc.34923. Online ahead of print. Int J Cancer. 2024. PMID: 38520231
Applying competing risks analysis to recurrences of primary breast cancer.
Mancini S, Biggeri A, Giuliani O, Vattiato R, Baldacchini F, Ravaioli A, Zamagni F, Falcini F, Bucchi L. Mancini S, et al. Among authors: ravaioli a. Epidemiol Prev. 2023 Nov-Dec;47(6):363-373. doi: 10.19191/EP23.6.A600.084. Epidemiol Prev. 2023. PMID: 38318787 Free article. English.
The descriptive epidemiology of melanoma in Italy has changed - for the better.
Bucchi L, Mancini S, Crocetti E, Dal Maso L, Baldacchini F, Vattiato R, Giuliani O, Ravaioli A, Zamagni F, Bella F, Bidoli E, Caldarella A, Candela G, Carone S, Carrozzi G, Cavallo R, Ferrante M, Ferretti S, Filiberti RA, Fusco M, Gatti L, Gili A, Iacovacci S, Magoni M, Mangone L, Mazzoleni G, Michiara M, Musolino A, Piffer S, Piras D, Rizzello RV, Rosso S, Rugge M, Scala U, Stracci F, Tagliabue G, Toffolutti F, Tumino R, Biggeri A, Masini C, Ridolfi L, Villani S, Palmieri G, Stanganelli I, Falcini F; Italian Melanoma Intergroup and the AIRTUM Working Group. Bucchi L, et al. Among authors: ravaioli a. Ital J Dermatol Venerol. 2023 Dec;158(6):483-492. doi: 10.23736/S2784-8671.23.07653-3. Ital J Dermatol Venerol. 2023. PMID: 38015485 Free article.
Complete prevalence and indicators of cancer cure: enhanced methods and validation in Italian population-based cancer registries.
Toffolutti F, Guzzinati S, De Paoli A, Francisci S, De Angelis R, Crocetti E, Botta L, Rossi S, Mallone S, Zorzi M, Manneschi G, Bidoli E, Ravaioli A, Cuccaro F, Migliore E, Puppo A, Ferrante M, Gasparotti C, Gambino M, Carrozzi G, Stracci F, Michiara M, Cavallo R, Mazzucco W, Fusco M, Ballotari P, Sampietro G, Ferretti S, Mangone L, Rizzello RV, Mian M, Cascone G, Boschetti L, Galasso R, Piras D, Pesce MT, Bella F, Seghini P, Fanetti AC, Pinna P, Serraino D, Dal Maso L; AIRTUM Working Group. Toffolutti F, et al. Among authors: ravaioli a. Front Oncol. 2023 Jun 6;13:1168325. doi: 10.3389/fonc.2023.1168325. eCollection 2023. Front Oncol. 2023. PMID: 37346072 Free PMC article.
Prevalence of a BRCA2 Pathogenic Variant in Hereditary-Breast-and-Ovarian-Cancer-Syndrome Families with Increased Risk of Pancreatic Cancer in a Restricted Italian Area.
Zampiga V, Cangini I, Bandini E, Azzali I, Ravegnani M, Ravaioli A, Mancini S, Tebaldi M, Tedaldi G, Pirini F, Veneroni L, Frassineti GL, Falcini F, Danesi R, Calistri D, Arcangeli V. Zampiga V, et al. Among authors: ravaioli a. Cancers (Basel). 2023 Apr 3;15(7):2132. doi: 10.3390/cancers15072132. Cancers (Basel). 2023. PMID: 37046793 Free PMC article.
Trends in Net Survival from Vulvar Squamous Cell Carcinoma in Italy (1990-2015).
Mancini S, Bucchi L, Zamagni F, Baldacchini F, Crocetti E, Giuliani O, Ravaioli A, Vattiato R, Preti M, Tumino R, Ferretti S, Biggeri A, Ballotari P, Boschetti L, Brustolin A, Caldarella A, Cavallo R, Cirilli C, Citarella A, Contrino ML, Dal Maso L, Filiberti RA, Fusco M, Galasso R, Lotti FL, Magoni M, Mangone L, Masanotti G, Mazzoleni G, Mazzucco W, Melcarne A, Michiara M, Pesce P, Pinto A, Piras D, Rizzello RV, Rognoni M, Rosso S, Rugge M, Sampietro G, Scalzi S, Scuderi T, Tagliabue G, Toffolutti F, Vitarelli S, Falcini F; AIRTUM Working Group. Mancini S, et al. Among authors: ravaioli a. J Clin Med. 2023 Mar 10;12(6):2172. doi: 10.3390/jcm12062172. J Clin Med. 2023. PMID: 36983173 Free PMC article.
236 results